4th Annual Lung Cancer Awareness Provider Dinner Dr. Jason Porter is hosting an insightful evening of discussion, collaboration, and networking focused on the latest advancements in lung cancer research, treatment, and care. All surrounding providers are invited to join! Date: Monday, December 2, 2024 Location: Capital Grille – Memphis Happy Hour: 6pm / Dinner &… Read more »
Posts Tagged: dr. Jason Porter
Lung Screening
2024 Think Pink Luncheon
Our West family is so proud to support the annual Think Pink Memphis luncheon! <br> This weekend, Dr. Jason Porter and Dr. Carmel Verrier participated in the expert panel discussion, sharing information about: Screening guidelines Current treatment and surgical options Importance of physical therapy for pre- and post-surgery Resources available across the Mid-South <br> This… Read more »
The Latest in Lung Cancer Research with Dr. Jason Porter
Tuesday, September 19 at 5pm EST Join Dr. Jason Porter for a live, dynamic discussion about the critical role of biomarker testing and clinical trials in lung cancer! Dr. Porter will partner with Estelamari Rodriguez, MD, MPH from the University of Miami’s Sylvester Comprehensive Cancer Center and moderator Terric Conneran, Founder of KRAS Kickers, to… Read more »
Exciting News in Lung Cancer Treatment, ft. Dr. Jason Porter
Exciting News in Lung Cancer Treatment Dr. Jason Porter joins Dr. Maya Khalil, Dr. Brian Mitzman, and Dr. Rami Manochakian in discussing the strides made in improving patient outcomes with immunotherapy and targeted therapies for non-small cell lung cancer (NSCLC). The group talks about several new clinical trials demonstrating promising results for high… Read more »
Dr. Jason Porter as Featured Guest on The Research Evangelist Podcast
Our very own Dr. Jason Porter was a recent guest on the Research Evangelist Podcast. This podcast hosts weekly discussions with leaders in the lung cancer research community. Host, David Bjork, is a lung cancer survivor himself and patient advocate. He and Dr. Porter discuss molecularly-altered lung cancers, as well as those lung cancers with… Read more »